XML 47 R38.htm IDEA: XBRL DOCUMENT
v3.23.3

License and Collaboration Agreements (Details) - USD ($) | 9 Months Ended |  |  |  |
--- | --- | --- | --- | --- | ---
Sep. 30, 2023 | Apr. 30, 2017 | Feb. 28, 2017 | Dec. 31, 2015 | Nov. 05, 2015
Monash License |  |  |  |  |
License and Collaboration Agreements |  |  |  |  |
Period of written notice to terminate | 30 days |  |  |  |
Licensing Agreement | Scripps Research Institute |  |  |  |  |
License and Collaboration Agreements |  |  |  |  |
Minimum annual fee |  |  |  | $ 25,000 |
Aggregate potential milestone payments | $ 2,600,000 |  |  |  |
Period of written notice to terminate | 90 days |  |  |  |
Licensing Agreement | Scripps Research Institute | Research and development |  |  |  |  |
License and Collaboration Agreements |  |  |  |  |
One-time cash payment |  |  |  | $ 10,000 |
Licensing Agreement | Vernalis (R&D) Limited |  |  |  |  |
License and Collaboration Agreements |  |  |  |  |
Milestone payments made | $ 0 |  | $ 3,000,000.0 |  |
Period of written notice to terminate | 90 days |  |  |  |
Licensing Agreement | Vernalis (R&D) Limited | Maximum |  |  |  |  |
License and Collaboration Agreements |  |  |  |  |
Aggregate potential milestone payments | $ 220,000,000 |  |  |  |
Licensing Agreement | Vernalis (R&D) Limited | Research and development |  |  |  |  |
License and Collaboration Agreements |  |  |  |  |
One-time cash payment |  |  |  |  | $ 1,000,000.0
Licensing Agreement | Monash License |  |  |  |  |
License and Collaboration Agreements |  |  |  |  |
Minimum annual fee |  | $ 25,000 |  |  |
Milestone payments made | 0 |  |  |  |
Licensing Agreement | Monash License | Maximum |  |  |  |  |
License and Collaboration Agreements |  |  |  |  |
Aggregate potential milestone payments | $ 45,100,000 |  |  |  |
Licensing Agreement | Monash License | Research and development |  |  |  |  |
License and Collaboration Agreements |  |  |  |  |
One-time cash payment |  | $ 275,000 |  |  |

X
- Definition The aggregate potential amount of payments the entity may be required to make to the counterparty based on achievement of milestones under the license or collaboration agreement. + References No definition available. + Details
Name: | crvs_LicenseAndCollaborationAgreementsAggregatePotentialMilestonePayments
Namespace Prefix: | crvs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of payments to the entity that are required to be made to the counterparty based on achievement of milestones under the license or collaboration agreement. + References No definition available. + Details
Name: | crvs_LicenseAndCollaborationAgreementsMilestonePaymentsMade
Namespace Prefix: | crvs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The minimum annual fee the entity is obligated to pay to the counterparty under the license or collaboration agreement. + References No definition available. + Details
Name: | crvs_LicenseAndCollaborationAgreementsMinimumAnnualFee
Namespace Prefix: | crvs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Period of written notice the entity is required to provide for termination of the license or collaboration agreement. + References No definition available. + Details
Name: | crvs_LicenseAndCollaborationAgreementsPeriodOfWrittenNoticeForTermination
Namespace Prefix: | crvs_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of a one-time cash payment made to the counterparty upon entering into a license or collaboration agreement. + References No definition available. + Details
Name: | crvs_LicenseAndCollaborationAgreementsUpfrontCashPaymentMade
Namespace Prefix: | crvs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=crvs_MonashLicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=crvs_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=crvs_ScrippsResearchInstituteMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=crvs_VernalisRAndDLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |